Stay updated with breaking news from Hal Barron. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
GlaxoSmithKline's chief scientific officer Hal Barron, left, is leaving to run a new privately-owned biotech start-up backed by Jeff Bezos that hopes to reverse the ageing process.
The backers of the company where scientist Hal Barron is set to become chief executive and co-chairman reportedly include Amazon founder Jeff Bezos and Russian... 20.01.2022, Sputnik International
FTSE 100 Falls as UK Inflation Soars 0853 GMT - The FTSE 100 falls 0.1% to 7558 points as investors react to data showing U.K. inflation accelerated to its highest level in nearly 30 years in...
SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ -- Altos Labs™ (Altos™) launched today as a new biotechnology company dedicated to unraveling the deep b...
LONDON – GlaxoSmithKline said on Wednesday